Arcellx Inc

NASDAQ:ACLX

67.16

+0.82 (+1.24%)

4:20:00 PM EDT: $67.16 0.00 (0.00%)

Market Cap (Intraday)	3.75B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$13.52 Million
Adjusted EPS	-$1.02

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Arcellx Inc Stock, NASDAQ:ACLX

25 West Watkins Mill Road, Suite A, Gaithersburg, Maryland 20878

United States of America

Phone: +1.240.327.0603

Number of Employees: 163

http://www.arcellx.com

Description

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.